STANZAMINE

Stanzamine is an experimental compound with limited therapeutic use, noted for neuroactive or sympathomimetic effects. Side effects may include agitation, tachycardia, headache, and nausea. Only GMP materials will be supplied, logistics all according to GDP.

SKU: a4260c1da06c Category: Tag:

Product Description


Mechanism of Action

STANZAMINE exhibits a broad and highcomplexity biochemical activity spectrum, modulating hierarchical signalling cascades, deep enzymatic networks, mitochondrial functional architecture, cytoskeletal integrity, transcriptionfactor coordination and multiaxis stressresponse systems. Its molecular conformation supports interaction with catalytic pockets, allosteric microdomains, transmembrane helices, regulatory scaffolds, ionchannel architectures and redoxbuffering systems, producing wideranging effects across metabolic, genomic, structural and electrophysiological layers.

Mechanistically, STANZAMINE may alter phosphorylation topologies, reshape signallingcascade propagation (ERK, JNK, MAPK, PI3KAKT), amplify or suppress secondmessenger concentrations (Ca²⁺, cAMP, IP, DAG), modify mitochondrial membrane polarity, shift ATP/ADP cycling behaviour, regulate ROSleakage thresholds and influence global metabolic flux distribution. Its capacity to integrate signals from cytosolic, organellebound and membraneanchored proteins makes it suitable for advanced mechanistic interrogation.

HighLevel

  • Deep kinomemapping & systemslevel pathwayinterference analysis
  • Structural docking, ligandstability modelling & conformational dynamics
  • Mitochondrialstress analysis including ETC complex modelling
  • UPR, ERstress & integrated autophagy/mitophagy evaluation
  • Multiomics network reconstruction (RNAseq, phosphoproteomics, metabolomics)
  • Membranedynamics and cytoskeletal mechanotransduction studies
  • Advanced cellfate modelling across apoptosis, necroptosis & ferroptosis axes
  • Predictive SAR/QSAR pipelines using machinelearning optimisation

Toxicodynamics & Cellular Risk Spectrum

  • Rapid ROS escalation & antioxidant-system saturation
  • Mitochondrial fragmentation or ETC suppression
  • Severe ionic-flux dysregulation (Ca²⁺, Na⁺, K⁺)
  • Cytoskeletal collapse & membrane-integrity compromise
  • Inflammatory upregulation (NF-κB, STAT, IRF)
  • Activation of programmed-cell-death pathways
  • Epigenetic drift involving methylation & acetylation instability

For expert not for biological or therapeutic exposure.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C16H22ClN3

Molecular Weight

291.82 g/mol

CAS Number

154-69-8

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

greater than or equal to 100 mg/mL at 72 °F (NTP, 1992)

Purity

Purity information is available upon request (COA).

Synonym

Tripelennamine hydrochloride; 154-69-8; Tripelennamine Hcl; Dehistin; Pyrinamine

IUPAC/Chemical Name

N'-benzyl-N,N-dimethyl-N'-pyridin-2-ylethane-1,2-diamine;hydrochloride

InChl Key

FSSICIQKZGUEAE-UHFFFAOYSA-N

InChl Code

InChI=1S/C16H21N3.ClH/c1-18(2)12-13-19(16-10-6-7-11-17-16)14-15-8-4-3-5-9-15;/h3-11H,12-14H2,1-2H3;1H

References

https://pubchem.ncbi.nlm.nih.gov/compound/9066;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download